Wearable Injector are Devices Which Adhere to the Body and Help in Administering Drug to the Patient
Wearable Injector |
A wearable injector is a medical device that enables the user to administer drugs through the skin. Injectors can be either prefilled or unfilled and are compatible with a variety of drugs. In addition, they are safe and convenient to use. There are several companies that have announced their intentions to develop such a device. Injectors can reduce the number of trips to the hospital for medication delivery. These devices are particularly useful for people who need to receive large volumes of medication and are not able to carry a syringe. The wearable device helps patients reduce the risk of acquiring infections while away from their homes.
Several companies are developing wearable patch injectors that adhere to the patient's skin and administer liquid pharmaceuticals subcutaneously. These products can reduce the number of trips to the hospital and improve patient compliance and quality of life. Furthermore, the technology can also help increase adherence to therapy, which could save billions of dollars a year.
According to Coherent Market Insights the Wearable Injector Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028.
Wearable injectors are becoming increasingly popular in home care settings. The growing demand for these devices is driving technological advancements in these devices. However, the lack of reimbursement is affecting the availability of these products. The investigational WI is designed for self-administration and caregiver administration, and it features a prefilled reservoir and multiple integrated functions. The device also has audible and visual injection progress indicators. The application of the device is modeled after the user's daily activities.
The investigational WI delivered a five-mL volume injection into subcutaneous tissue without pain and in 5.5 minutes. Users reported minimal discomfort and a willingness to use the device if prescribed. The investigational WI had no adverse effects and was well-accepted by the subjects in both gender and age groups. Its usability and feasibility would improve as more subjects with relevant chronic diseases are included in trials. The BD Liberates Injector, an investigational injector, is designed to deliver biologics with a viscosity of 50 cP. The device comes in two and five-mL configurations. Each can deliver eight cP injections. Medtronic plc launched their first Medtronic Extended infusion set in April 2021, which helps in transferring insulin to the body from the pump. This device can be worn for 7 days.
Comments
Post a Comment